Markets & Regulations

© Getty Images

Verici Dx receives boost with Thermo Fisher licensing deal

By Isabel Cameron

Verici Dx, a company developing advanced clinical diagnostics for organ transplant, has entered into a global licensing partnership with healthcare giant Thermo Fisher to develop an assay for pre-transplant kidney testing.

© Getty Images

Not-for-profit alliance advocates for life sciences collaboration

By Liza Laws

The Pistoia Alliance is a global, not-for-profit alliance that advocates for greater collaboration in life sciences R&D. It has just announced its four new strategic priorities made up of global pharma and tech representatives to deliver new project...

© Getty Images

WuXi Biologics bioconjugates spinout plans $470 million IPO

By Liza Laws

The Chinese contract research, development and manufacturing organization (CRDMO) WuXi XDC has launched a bid to raise up to HK$3.7 billion (US$470.3 million) in an initial public offering (IPO) on the Hong Kong Stock Exchange.

© Getty Images

BioCina to manufacture pneumococcal vaccines in expanded partnership

By Jonathan Smith

The Australian biotech GPN Vaccines has expanded a partnership with compatriot contract development and manufacturing organization (CDMO) BioCina to scale up the manufacture of its lead candidate vaccine against pneumococcal diseases such as pneumonia,...

© Getty Images

Atara licenses T cell therapy to Pierre Fabre for up to $640 million

By Jonathan Smith

As it extends its cash runway, the cell therapy developer Atara Biotherapeutics has expanded a partnership with Pierre Fabre Laboratories to commercialize the off-the-shelf T-cell therapy tabelecleucel (tab-cel) for a rare form of blood cancer.

Sanofi invests $30m in MeiraGTx’s gene therapy pipeline

Sanofi invests $30m in MeiraGTx’s gene therapy pipeline

By Jonathan Smith

The London and New York-based gene therapy player MeiraGTx Holdings has received a $30 million investment from Sanofi in addition to potential strategic deals with the big pharma company down the road.

© Getty Images

ADC licensing deals reached peak of $16.6 billion in 2022

By Isabel Cameron

The biopharmaceutical industry witnessed a 400% growth in total deal value of antibody-drug conjugate (ADC) licensing agreements from 2017-2022 and reached a peak of $16.6 billion in 2022, reveals data and analytics company GlobalData.

© Getty Images

SOTIO expands ADC pipeline with Synaffix tie up

By Isabel Cameron

Synaffix, a Lonza company commercializing its clinical-stage platform technology for the development of antibody-drug conjugates (ADCs), has entered a licensing agreement with SOTIO, a clinical stage immuno-oncology company owned by PPF Group.

© Getty Images

Congenica extends contract with Hong Kong Genome Project

By Isabel Cameron

Congenica, a digital health company providing software and solutions for the analysis and interpretation of genomic data at scale, has announced a two-year extension to its contract for the Hong Kong Genome Project (HKGP), the first large-scale genome...

© Sharp

Breaking: Sharp acquires Berkshire Sterile Manufacturing

By Isabel Cameron

Sharp, a commercial pharma packaging and clinical trial supply services firm, has acquired Berkshire Sterile Manufacturing (BSM), a Massachusetts-based fill finish contract development and manufacturing organization (CDMO).